Purpose: Our study addresses at the benefit of surveillance of probably benign lesions, detected outside mammographic screening, during a 3-year period.
Methods: 28,588 women (mean age 57 ± 12 years) were examined. Two independent radiologists read the mammogram as well as the supplemented ultrasound (in case of breast density ACR type 3 and 4). In the case of discordance a third expert considered whether further examination was indicated or not.
Results: 3,266 diagnostic procedures ended with BI-RADS 3 result and 2,512 (76.9 %) women underwent a follow-up examination. 295 (11.7 %) of them received assessment examination (imaging and/or biopsy) and 37 (12.5 %) (none of them palpable) ended with BI-RADS 6. This equals a tumor detection rate of 14.7/1,000. The ratio in situ:invasive was 7:10 (1:1.43) and the mean size was 11.1 ± 4.51 mm. In the total cohort, 536 carcinomas ended with BI-RADS 6 of them 17 % were in situ and 83 % were invasive breast cancers (ratio in situ:invasive 1:4.99), mean size was 13.8 ± 6.3 mm. The cancer detection ratio in these cases was 18.7/1,000.
Conclusions: The amount of detected tumors at follow-up of women with preceding BI-RADS 3 equates the associated potential of malignancy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00404-014-3233-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.
Eur Radiol
November 2024
Department of Radiological, Pathological and Oncological Sciences, Sapienza University of Rome, Rome, Italy.
Importance: Breast cancer is one of the leading causes of negligence claims in radiology. The objective of this document is to describe the specific main causes of errors in breast imaging and provide European Society of Breast Imaging (EUSOBI) recommendations to try to minimize these.
Observations: Technical failures represent 17% of all mammographic diagnostic negligence claims.
Diagnostic value of qualitative and quantitative enhancement parameters on contrast-enhanced mammography.
Diagn Interv Radiol
July 2024
Karadeniz Technical University, Faculty of Medicine, Department of Radiology, Trabzon, Türkiye
Purpose: To determine whether qualitative and quantitative enhancement parameters obtained from contrast-enhanced mammography (CEM) can be used in predicting malignancy.
Methods: After review board approval, consecutive 136 suspicious lesions with definite diagnosis were retrospectively analyzed on CEM. Acquisition was routinely started with craniocaudal view and ended with mediolateral oblique view of the affected breast.
Preoperative breast MRI positively impacts surgical outcomes of needle biopsy-diagnosed pure DCIS: a patient-matched analysis from the MIPA study.
Eur Radiol
June 2024
Unit of Radiology, IRCCS Policlinico San Donato, Via Rodolfo Morandi 30, 20097, San Donato Milanese, Italy.
Article Synopsis
- The study looked at how having an MRI before surgery affects the chances of needing a mastectomy or having to have more surgery for women with ductal carcinoma in situ (DCIS), a type of breast cancer.
- They compared two groups of patients: one that had MRIs before surgery and one that didn't, looking closely at various factors that could affect the results.
- The results showed that women who had the MRI were more likely to have a mastectomy but were less likely to need additional surgeries afterwards.
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision.
Insights Imaging
July 2023
Department of Imaging, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.
Axillary lymphadenopathy is a common side effect of COVID-19 vaccination, leading to increased imaging-detected asymptomatic and symptomatic unilateral axillary lymphadenopathy. This has threatened to negatively impact the workflow of breast imaging services, leading to the release of ten recommendations by the European Society of Breast Imaging (EUSOBI) in August 2021. Considering the rapidly changing scenario and data scarcity, these initial recommendations kept a highly conservative approach.
View Article and Find Full Text PDFDense Breast Notification Letters: What Do Breast Radiologists Think?
J Breast Imaging
June 2020
Alpert Medical School of Brown University, Rhode Island Hospital, Department of Diagnostic Imaging, Providence, RI.
Objective: The Food and Drug Administration is currently creating national standards for language used in letters sent to women after mammography concerning dense breasts. The purpose of the current study is to survey breast radiologists on their opinions about language to be included in dense breast notification (DBN) letters.
Methods: An anonymous survey (17 questions and 10 open-ended response fields) was sent to Society of Breast Imaging members between May 2019 and June 2019.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!